Wed, 24 Sep 2025
His comments come after pharmaceutical giants either paused or scrapped projects in the UK.
* Low prices, lack of government investment, and US tariff pressure are driving firms away from the UK, critics say
* Lord Vallance: "price increases are going to be a necessary part" of solving the problem, but didn't specify where extra funding would come from
* Health Secretary Wes Streeting says there's a "live conversation" between government departments and pharma industry on drug pricing
* Moderna invests £1bn in UK research and development as part of 10-year partnership to create new treatments, jobs, and boost pandemic resilience
* Several pharmaceutical firms have recently paused or scrapped UK projects due to low prices and lack of investment
* US pressure under President Donald Trump is also driving firms away from the UK to invest in the US instead.
>>
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025